Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07114614 · ClinicalTrials.gov registry record
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- 120
- Enrollment target
NCT07114614 is a clinical trial that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 120 participants.
The verdict
NCT07114614 is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate whether cancer survivors have higher levels of proteins called Fatty Acid Binding Proteins as well as 12 different markers of cellular senescence than people who have never had cancer. Investigators believe that these levels may be elevated in cancer survivors as a result of their cancer and the treatments they received and may put them at higher risk for chronic conditions such as high cholesterol, diabetes, high blood pressure, and obesity. This study will also compare the levels of these proteins and inflammatory markers in the blood with different aspects of cancer treatment the survivors received. Investigators are investigating if there is a correlation between levels of these proteins and markers, the type of treatment cancer survivors received, and development of metabolic conditions.
Interventions
- OTHER Specimen #1
- OTHER Specimen #2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07114614
The ClinicalTrials.gov registry entry for NCT07114614 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Specimen #1 is the first listed.
NCT07114614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07114614 about?
NCT07114614 is a clinical study titled "Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors". The purpose of this research study is to investigate whether cancer survivors have higher levels of proteins called Fatty Acid Binding Proteins as well as 12 different markers of cellular senescence than people who have never had cancer. Investigators believe that these levels may be elevated in can...
What is the current status of trial NCT07114614?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2026-07. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07114614?
The interventions under investigation include: Specimen #1 (OTHER), Specimen #2 (OTHER).
Who is sponsoring clinical trial NCT07114614?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.